¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é, ¼¼°è ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 17¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 7.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù. ³ë·É Àα¸¿Í Àå¾ÖÀÎ Àα¸ Áõ°¡¿Í ÀçÅÃÄ¡·á Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ³ë³âÃþÀº ÀÌ ½ÃÀåÀÇ ÁÖ¿ä Ÿ°Ù Àα¸ÀÔ´Ï´Ù. ÀÌ °èÃþÀº ³ëÈ·Î ÀÎÇÑ Àå¾Ö¿¡ ¸Å¿ì Ãë¾àÇϸç, °æ¿ì¿¡ µû¶ó¼´Â ¿òÁ÷ÀÏ ¼ö ¾ø°Ô µÉ ¼öµµ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àå±â¿ä¾ç¼¾ÅÍ¿Í ³ëÀοä¾ç¼¾ÅÍÀÇ ÃâÇöÀº ½ÃÀå ±â¾÷µé¿¡°Ô ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.
2020³â Äڷγª19ÀÇ ¹ß»ýÀº ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀåÀÇ ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆÀ¸¸ç, Äڷγª19 ȯÀÚ ¼ö Áõ°¡¿Í ÀΰøÈ£Èí±â Áö¿ø¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä·Î ÀÎÇØ ÀÔ¿ø Áß Áö¿ø º¸Á¶±â±¸ÀÇ Á߿伺ÀÌ ±ÞÁõÇß½À´Ï´Ù. ¶ÇÇÑ, ¼¼°èº¸°Ç±â±¸(WHO)´Â Äڷγª19 ȯÀÚ °ü¸®¿Í °ü·ÃÇÏ¿© ÀÏȸ¿ë ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ¹× ±âŸ ±â±¸ »ç¿ë¿¡ ´ëÇÑ ÁöħÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ±â¾÷µé¿¡°Ô Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ, ¼¼°èº¸°Ç±â±¸(WHO)°¡ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é Àü ¼¼°è Àα¸ÀÇ ¾à 15%°¡ Àå¾Ö¸¦ °¡Áö°í ÀÖÀ¸¸ç, ±× Áß 2-4%´Â ±â´É Àå¾Ö¸¦ °æÇèÇϰí ÀÖ½À´Ï´Ù. ±× Áß 2 - 4%ÀÇ Àα¸°¡ ±â´É Àå¾Ö¸¦ °æÇèÇϰí ÀÖÀ¸¸ç, 80 ¼¼ ÀÌ»óÀÇ ³ëÀÎÀº Àå¾Ö¸¦ °¡Áú °¡´É¼ºÀÌ ¾à 8 ¹è ´õ ³ô½À´Ï´Ù. ¹Ì±¹ Àα¸Á¶»ç±¹ÀÌ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é, ¾à 1,990¸¸ ¸íÀÌ µé¾î¿Ã¸®°Å³ª Àâ´Â µ¥ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸ðµç ¿äÀεéÀÌ À̵¿À» À§ÇÑ ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ°ú °°Àº º¸Á¶±â±¸ÀÇ Çʿ伺¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.
ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå º¸°í¼ - ÁÖ¿ä ³»¿ë
- Á¦Ç°º°·Î´Â ³ªÀÏ·Ð ½½¸µ ºÎ¹®ÀÌ 2023³â 29.65%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGRÀ» º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.
- ¿ëµµº°·Î´Â ÀÌ¼Û¿ë ½½¸µ ºÎ¹®ÀÌ 2023³â 29.35%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¿ìÀ§´Â ÀÇÀÚ, ħ´ë ¹× ¹Ù´ÚÀ¸·Î ȯÀÚ¸¦ ¿Å±â´Â °Í°ú °°Àº ¿ëµµ¿¡ ±âÀÎÇÕ´Ï´Ù.
- ÃÖÁ¾ ¿ëµµº°·Î´Â º´¿ø ºÐ¾ß°¡ 2023³â 46.38%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. ¹æ´ëÇÑ È¯ÀÚ ¼ö¿Í ³ôÀº ÀÚ±Ý Á¶´Þ ´É·ÂÀº º´¿ø¿¡¼ ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µÀÇ ´ë·® ±¸¸Å¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
- ºÏ¹Ì´Â 2023³â 32.25%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ¿ìÀ§´Â ¹Ì±¹°ú ij³ª´Ù¿¡¼ ½ÉÇ÷°ü Áúȯ(CVD) ¹× ´ç´¢º´°ú °°Àº ´Ù¾çÇÑ »ýȰ½À°üº´À¸·Î ÀÎÇÑ ¸¸¼ºÁúȯ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå : Á¶»ç ¹æ¹ý·Ð°ú ¹üÀ§
Á¦2Àå ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå : ÁÖ¿ä ¿ä¾à
- ½ÃÀå Àü¸Á
- ºÎ¹® Àü¸Á
- °æÀï ÀλçÀÌÆ®
Á¦3Àå ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå : º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå ºÐ¼® Åø
Á¦4Àå ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®
- Á¦Ç° ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
- ºÎ¹® ´ë½Ãº¸µå
- Á¦Ç°º° ¼¼°èÀÇ ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
- Nylon Slings
- Padded Slings
- Mesh Slings
- Canvas Slings
- ±âŸ
Á¦5Àå ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ¿ëµµ ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
- ºÎ¹® ´ë½Ãº¸µå
- ¿ëµµº° ¼¼°èÀÇ ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
- Transfer Slings
- Universal Slings
- Hammock Slings
- Standing Slings
- Seating Slings
- Toileting Slings
- Bariatric Slings
- ±âŸ
Á¦6Àå ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå : »ç¿ë ÃßÁ¤¡¤µ¿Ç⠺м®
- »ç¿ë ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
- ºÎ¹® ´ë½Ãº¸µå
- ¿ëµµº° ¼¼°èÀÇ ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
Á¦7Àå ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2023³â ¹× 2030³â
- ºÎ¹® ´ë½Ãº¸µå
- ÃÖÁ¾ ¿ëµµº° ¼¼°èÀÇ ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð, ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
- º´¿ø
- ȨÄɾî
- °í·ÉÀÚ Äɾî
- ±âŸ ÀÇ·á½Ã¼³
Á¦8Àå ÀÇ·á¿ë ¸®ÇÁÆÃ ½½¸µ ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
- Áö¿ª ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
- Áö¿ª ½ÃÀå ´ë½Ãº¸µå
- ¼¼°èÀÇ Áö¿ª ½ÃÀå ½º³À¼ô
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â
- ºÏ¹Ì
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ÀϺ»
- Áß±¹
- Àεµ
- È£ÁÖ
- Çѱ¹
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- Äí¿þÀÌÆ®
Á¦9Àå °æÀï ±¸µµ
- ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
- ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
- Arjo
- Invacare Corporation.
- Baxter(Hill-Rom)
- Joerns Healthcare
- Prism Healthcare Ltd
- DJO, LLC
- Spectracare
- V. Guldmann A/S
- Silvalea ltd
- Etac AB
LSH 24.03.25
Medical Lifting Sling Market Growth & Trends:
The global medical lifting sling market size is anticipated to reach USD 1.74 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.6% from 2024 to 2030. Expanding geriatric and disabled population coupled with rising need for home healthcare products are propelling the market growth. Geriatric population forms the target population for this market. This demographic is highly susceptible to age-related disorders that in certain cases causes immobility. Moreover, the advent of long-term care centers and elderly care centers is creating growth opportunities for market players.
The outbreak of COVID-19 in the year 2020 has positively impacted the medical lifting sling market growth. Increased number of COVID-19 cases and high demand for ventilator support, surged the importance of having supporting aids during the entire stay in hospital. In addition, WHO published the guidance for using disposable medical lifting slings and other equipment, regarding the management of COVID-19 patients. These factors are anticipated to create huge growth opportunities for market players over the forecast period.
Moreover, the prevalence of disabilities is also boosting the demand for the slings. As per the data published by WHO, around 15% of the world's population lives with some form of disability. Out of those some 2% to 4% population experience difficulties in functioning. Old people of 80 years or above are about eight times more likely to have a disability. As per the data published by the U.S. Census Bureau, around 19.9 million people had difficulty in lifting and grasping. All these factors are positively influencing the need for assistive devices like medical lifting slings to obtain mobility.
Medical Lifting Sling Market Report Highlights:
- Based on product, the nylon slings segment led the market in 2023 with the largest revenue share of 29.65%. It is also expected to grow fastest CAGR over the forecast period.
- In terms of application, the transfer slings segment led the market with the largest revenue share of 29.35% in 2023. The dominance of the segment can be attributed to its application, which includes transferring patients to and or from a chair, bed, and the floor.
- Based on end-use, the hospital segment led the market with a largest revenue share of 46.38% in 2023. The huge patient pool and a greater financing capability facilitate bulk purchasing of medical lifting slings in hospitals.
- North America dominated the market with a revenue share of 32.25% in 2023. The dominance of the region is due to increasing chronic diseases resulting from various lifestyle diseases such as cardiovascular disease (CVD) and diabetes in the U.S. and Canada.
Table of Contents
Chapter 1. Medical Lifting Sling Market: Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. Usage
- 1.2.4. End-use
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Medical Lifting Sling Market: Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Usage Outlook
- 2.2.4. End-use outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Medical Lifting Sling Market: Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of chronic diseases requiring long-term care
- 3.2.1.2. Rapidly growing geriatric population
- 3.2.1.3. Increasing availability of home healthcare services and staff
- 3.2.2. Market restraint analysis
- 3.2.2.1. Lack of qualified staff
- 3.2.2.2. Performance failure and durability issues of medical lifting slings
- 3.3. Medical Lifting Sling Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. Pricing Analysis
Chapter 4. Medical Lifting Sling Market: Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Medical Lifting Sling Market by Product Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Nylon Slings
- 4.4.1.1. Nylon Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Padded Slings
- 4.4.2.1. Padded Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Mesh Slings
- 4.4.3.1. Mesh Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4. Canvas Slings
- 4.4.4.1. Canvas Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.5. Other Slings
- 4.4.5.1. Other Slings Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Medical Lifting Sling Market: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Medical Lifting Sling Market by Application Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Transfer Slings
- 5.4.1.1. Transfer Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Universal Slings
- 5.4.2.1. Universal Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Hammock Slings
- 5.4.3.1. Hammock Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Standing Slings
- 5.4.4.1. Standing Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Seating Slings
- 5.4.5.1. Seating Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.6. Toileting Slings
- 5.4.6.1. Toileting Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.7. Bariatric Slings
- 5.4.7.1. Bariatric Slings Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.8. Other Slings
- 5.4.8.1. Other Slings Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Medical Lifting Sling Market: Usage Estimates & Trend Analysis
- 6.1. Usage Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Medical Lifting Sling Market by Usage Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Reusable slings
- 6.4.1.1. Reusable slings market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Disposable slings
- 6.4.2.1. Disposable slings market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Medical Lifting Sling Market: End-use Estimates & Trend Analysis
- 7.1. End-use Market Share, 2023 & 2030
- 7.2. Segment Dashboard
- 7.3. Global Medical Lifting Sling Market by End-use Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.4.1. Hospitals
- 7.4.1.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. Homecare
- 7.4.2.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. Elderly care
- 7.4.3.1. Elderly care market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Others healthcare settings
- 7.4.4.1. Others healthcare settings market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Medical Lifting Sling Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2023 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 8.5. North America
- 8.5.1. U.S.
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework
- 8.5.1.3. Competitive scenario
- 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. Canada
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework
- 8.5.2.3. Competitive scenario
- 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6. Europe
- 8.6.1. UK
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework
- 8.6.1.3. Competitive scenario
- 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Germany
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.3. France
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Regulatory framework
- 8.6.3.3. Competitive scenario
- 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.4. Italy
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Regulatory framework
- 8.6.4.3. Competitive scenario
- 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.5. Spain
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Regulatory framework
- 8.6.5.3. Competitive scenario
- 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.6. Denmark
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Regulatory framework
- 8.6.6.3. Competitive scenario
- 8.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.7. Sweden
- 8.6.7.1. Key country dynamics
- 8.6.7.2. Regulatory framework
- 8.6.7.3. Competitive scenario
- 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.8. Norway
- 8.6.8.1. Key country dynamics
- 8.6.8.2. Regulatory framework
- 8.6.8.3. Competitive scenario
- 8.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7. Asia Pacific
- 8.7.1. Japan
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework
- 8.7.1.3. Competitive scenario
- 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. China
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework
- 8.7.2.3. Competitive scenario
- 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. India
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Regulatory framework
- 8.7.3.3. Competitive scenario
- 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.4. Australia
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Regulatory framework
- 8.7.4.3. Competitive scenario
- 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.5. South Korea
- 8.7.5.1. Key country dynamics
- 8.7.5.2. Regulatory framework
- 8.7.5.3. Competitive scenario
- 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.6. Thailand
- 8.7.6.1. Key country dynamics
- 8.7.6.2. Regulatory framework
- 8.7.6.3. Competitive scenario
- 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8. Latin America
- 8.8.1. Brazil
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Regulatory framework
- 8.8.1.3. Competitive scenario
- 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.2. Mexico
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Regulatory framework
- 8.8.2.3. Competitive scenario
- 8.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.3. Argentina
- 8.8.3.1. Key country dynamics
- 8.8.3.2. Regulatory framework
- 8.8.3.3. Competitive scenario
- 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9. MEA
- 8.9.1. South Africa
- 8.9.1.1. Key country dynamics
- 8.9.1.2. Regulatory framework
- 8.9.1.3. Competitive scenario
- 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.2. Saudi Arabia
- 8.9.2.1. Key country dynamics
- 8.9.2.2. Regulatory framework
- 8.9.2.3. Competitive scenario
- 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.3. UAE
- 8.9.3.1. Key country dynamics
- 8.9.3.2. Regulatory framework
- 8.9.3.3. Competitive scenario
- 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.4. Kuwait
- 8.9.4.1. Key country dynamics
- 8.9.4.2. Regulatory framework
- 8.9.4.3. Competitive scenario
- 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.2.1. Key company market share analysis, 2023
- 9.2.2. Arjo
- 9.2.2.1. Company overview
- 9.2.2.2. Financial performance
- 9.2.2.3. Product benchmarking
- 9.2.2.4. Strategic initiatives
- 9.2.3. Invacare Corporation.
- 9.2.3.1. Company overview
- 9.2.3.2. Financial performance
- 9.2.3.3. Product benchmarking
- 9.2.3.4. Strategic initiatives
- 9.2.4. Baxter (Hill-Rom)
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. Joerns Healthcare
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. Prism Healthcare Ltd
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. DJO, LLC
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. Spectracare
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. V. Guldmann A/S
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. Silvalea ltd
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives
- 9.2.11. Etac AB
- 9.2.11.1. Company overview
- 9.2.11.2. Financial performance
- 9.2.11.3. Product benchmarking
- 9.2.11.4. Strategic initiatives